215 related articles for article (PubMed ID: 11516922)
1. Lofexidine versus clonidine in rapid opiate detoxification.
Gerra G; Zaimovic A; Giusti F; Di Gennaro C; Zambelli U; Gardini S; Delsignore R
J Subst Abuse Treat; 2001 Jul; 21(1):11-7. PubMed ID: 11516922
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
3. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
[TBL] [Abstract][Full Text] [Related]
4. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
5. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
[TBL] [Abstract][Full Text] [Related]
6. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
[TBL] [Abstract][Full Text] [Related]
7. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Buntwal N; Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
[TBL] [Abstract][Full Text] [Related]
9. Clonidine in opiate withdrawal: review and appraisal of clinical findings.
Washton AM; Resnick RB
Pharmacotherapy; 1981; 1(2):140-6. PubMed ID: 6765486
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
Walsh SL; Strain EC; Bigelow GE
Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
[TBL] [Abstract][Full Text] [Related]
11. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
Strang J; Bearn J; Gossop M
Am J Addict; 1999; 8(4):337-48. PubMed ID: 10598217
[TBL] [Abstract][Full Text] [Related]
12. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal.
Lin SK; Strang J; Su LW; Tsai CJ; Hu WH
Drug Alcohol Depend; 1997 Nov; 48(2):127-33. PubMed ID: 9363412
[TBL] [Abstract][Full Text] [Related]
13. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
Kahn A; Mumford JP; Rogers GA; Beckford H
Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
[TBL] [Abstract][Full Text] [Related]
14. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings.
Sinha R; Kimmerling A; Doebrick C; Kosten TR
Psychopharmacology (Berl); 2007 Mar; 190(4):569-74. PubMed ID: 17136399
[TBL] [Abstract][Full Text] [Related]
15. Outpatient opiate detoxification with clonidine.
Washton AM; Resnick RB
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
[TBL] [Abstract][Full Text] [Related]
16. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
Carnwath T; Hardman J
Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
[TBL] [Abstract][Full Text] [Related]
17. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial.
Fishman M; Tirado C; Alam D; Gullo K; Clinch T; Gorodetzky CW;
J Addict Med; 2019; 13(3):169-176. PubMed ID: 30531234
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in opiate detoxification: clonidine and lofexidine.
Washton AM; Resnick RB
NIDA Res Monogr; 1983 Apr; 43():44-50. PubMed ID: 6410276
[No Abstract] [Full Text] [Related]
[Next] [New Search]